Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Cancer Discovery|July 24, 2021
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML TherapyHsin-Chieh Wu, Domitille Rérolle, Caroline Berthier, et al.
Blood|October 21, 2011
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeVera Grossmann, Enrico Tiacci, Antony B Holmes, et al.
Hematological Oncology|October 20, 2022
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohortMichele Merli, Isacco Ferrarini, Francesco Merli, et al.
Cancer Cell|April 16, 2015
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaRamona Crescenzo, Francesco Abate, Elena Lasorsa, et al.
Leukemia|May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelinesMichael Grever, Leslie Andritsos, Versha Banerji, et al.
Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Leukemia|June 8, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasmsMichael Grever, Leslie Andritsos, Mirela Anghelina, et al.
Blood Cancer Journal|December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemiaFarhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Blood|September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Cancer Discovery|July 24, 2021
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML TherapyHsin-Chieh Wu, Domitille Rérolle, Caroline Berthier, et al.
Blood|October 21, 2011
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeVera Grossmann, Enrico Tiacci, Antony B Holmes, et al.
Hematological Oncology|October 20, 2022
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohortMichele Merli, Isacco Ferrarini, Francesco Merli, et al.
Cancer Cell|April 16, 2015
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaRamona Crescenzo, Francesco Abate, Elena Lasorsa, et al.
Leukemia|May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelinesMichael Grever, Leslie Andritsos, Versha Banerji, et al.
Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Leukemia|June 8, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasmsMichael Grever, Leslie Andritsos, Mirela Anghelina, et al.
Blood Cancer Journal|December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemiaFarhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Blood|September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Pageof 25